Efficacy and Safety of COVID-19 Vaccine in Patients on Renal Replacement Therapy
Patients with CKD on RRT are at high risk for severe disease and mortality in COVID-19 disease. We decided to conduct an observational prospective study to evaluate antibody response after vaccination for COVID-19 in a cohort of 210 adult patients on RRT (148 on HD; 20 on PD; and 42 kidney transplan...
Main Authors: | Michela Frittoli, Matthias Cassia, Alessandra Barassi, Paola Ciceri, Andrea Galassi, Ferruccio Conte, Mario Gennaro Cozzolino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/9/1395 |
Similar Items
-
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
by: Paola Monciino, et al.
Published: (2022-09-01) -
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
by: Paola Ciceri, et al.
Published: (2022-09-01) -
Epidemiology of Renal Replacement Therapy in Macedonia
by: Olivera Stojceva-Taneva
Published: (2010-04-01) -
Trends in Renal Replacement Therapy in Bosnia and Herzegovina 2002-2008
by: Halima Resić, et al.
Published: (2010-04-01) -
Clinical-immunological parallels in chronic renal Failure in children
by: G. A. Makovetskaya, et al.
Published: (2023-03-01)